Partial approval for Amgen bone drug
Friday, August 14, 2009 - 11:21
in Health & Medicine
WASHINGTON, Aug. 14 (UPI) -- Amgen's bone drug, denosumab, has been partially endorsed by an advisory committee to the U.S. Food and Drug Administration, officials said.